Systematic development and characterization of curcumin-loaded nanogel for topical application

References

• Pinto MF, Moura CC, Nunes C, et al. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers. Int J Pharm. 2014;477(1-2):519–526.
   PubMedGoogle Scholar
• Boca AN, Ilies RF, Vesa S, et al. The first nation-wide study revealing epidemiologic data and life quality aspects of psoriasis in Romania. Exp Ther Med. 2019;18(2):900–904.
   PubMed Web of Science ®Google Scholar
• Griffiths C, Van der Walt J, Ashcroft D, et al. The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol. 2017;177(1):e4–e7.
   PubMed Web of Science ®Google Scholar
• Velappan R, Venu S, Ramasamy S, et al. Current scenario in clinical trends of psoriasis in tertiary care hospital. Int J Res Dermatol. 2019;5(3):452–456.
   Google Scholar
• Thappa DM, Munisamy M. Research on psoriasis in India: Where do we stand? Indian J Med Res. 2017;146(2):147–149.
   PubMedGoogle Scholar
• Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J. 2016;7(6):471–480.
   PubMedGoogle Scholar
• Langley R, Krueger G, Griffiths C. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64(suppl_2):ii18–ii23.
   PubMedGoogle Scholar
• Pradhan M, Singh D, Singh MR. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. J Control Release. 2013;170(3):380–395.
   PubMed Web of Science ®Google Scholar
• Colbert RA, Ward MM. JAK inhibitors taking on psoriatic arthritis. N Engl J Med. 2017;377(16):1582–1584.
   PubMed Web of Science ®Google Scholar
• Papp K, Gordon K, Thaçi D, et al. Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis. N Engl J Med. 2018;379(14):1313–1321.
   PubMed Web of Science ®Google Scholar
• Gottlieb AB. Novel immunotherapies for psoriasis: clinical research delivers new hope for patients and scientific advances. J Invest Dermatol Symp Proc. 2004;9(1):79–83.
   PubMed Web of Science ®Google Scholar
• Bhatia A, Singh B, Amarji B, et al. Novel stain-free lecithinized coal tar formulation for psoriasis . Int J Dermatol. 2011;50(10):1246–1248.
   PubMed Web of Science ®Google Scholar
• Wagner CM. Is the addition of a topical agent to narrowband UVB treatment more effective in treating male and female adults with psoriasis than narrowband treatment alone? PCOM Physician Assistant Studies Student Scholarship; 2014.
   Google Scholar
• Segaert S, Calzavara-Pinton P, de la Cueva P, et al. Long-term topical management of psoriasis: the road ahead. J Dermatolog Treat. 2020;5:1–10. DOI:10.1080/09546634.2020.1729335
   Google Scholar
• Sivamani RK, Correa G, Ono Y, et al. Biological therapy of psoriasis. Indian J Dermatol. 2010;55(2):161–170.
   PubMedGoogle Scholar
• Menter A, Korman NJ, Elmets CA, et al.; American Academy of Dermatology Work Group. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65(1):137–174.
   PubMed Web of Science ®Google Scholar
• Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445(7130):866–873.
   PubMed Web of Science ®Google Scholar
• Vollono L, Falconi M, Gaziano R, et al. Potential of curcumin in skin disorders. Nutrients. 2019;11(9):2169.
   Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–818.
   PubMed Web of Science ®Google Scholar
• Rapalli VK, Kaul V, Gorantla S, et al. UV spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: method development, in-vitro and ex-vivo applications in topical delivery. Spectrochim Acta A Mol Biomol Spectrosc. 2020;224:117392.
   PubMed Web of Science ®Google Scholar
• Sarafian G, Afshar M, Mansouri P, et al. Topical turmeric microemulgel in the management of plaque psoriasis; a clinical evaluation. Iran J Pharmaceut Res. 2015;14(3):865.
   PubMed Web of Science ®Google Scholar
• Naz Z, Ahmad FJ. Curcumin-loaded colloidal carrier system: formulation optimization, mechanistic insight, ex vivo and in vivo evaluation. Int J Nanomed. 2015;10:4293.
   PubMedGoogle Scholar
• Patel NA, Patel NJ, Patel RP. Formulation and evaluation of curcumin gel for topical application. Pharm Dev Technol. 2009;14(1):83–92.
   Web of Science ®Google Scholar
• Khiljee S, Rehman N, Sarfraz M, et al. In vitro release of Indian penny wort, walnut, and turmeric from topical preparations using two different types of membranes. Dissolution Technol. 2010;17(4):27–32.
   Web of Science ®Google Scholar
• Yousef SA, Mohammed YH, Namjoshi S, et al. Mechanistic Evaluation Of Enhanced Curcumin Delivery Through Human Skin In Vitro From Optimised Nanoemulsion Formulations Fabricated With Different Penetration Enhancers. Pharmaceutics. 2019;11(12):639.
   Web of Science ®Google Scholar
• Singhvi G, Hejmady S, Rapalli VK, et al. Nanocarriers for topical delivery in psoriasis. Chapter 4. In: Delivery of drug. Amsterdam: Elsevier; 2020.p.75–96.
   Google Scholar
• Suresh PK, Singh P, Saraf S. Novel topical drug carriers as a tool for treatment of psoriasis: progress and advances. Afr J Pharm Pharmacol. 2013;7(5):138–147.
   Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161–177.
   PubMed Web of Science ®Google Scholar
• Bishnoi M, Jain A, Singla Y, et al. Sublingual delivery of chondroitin sulfate conjugated tapentadol loaded nanovesicles for the treatment of osteoarthritis. J Liposome Res. 2020:1–33.DOI: 10.1080/08982104.2020.1730400
   PubMed Web of Science ®Google Scholar
• Jain A, Kumari R, Tiwari A, et al. Nanocarrier based advances in drug delivery to tumor: an overview. Curr Drug Targets. 2018;19(13):1498–1518.
   PubMed Web of Science ®Google Scholar
• Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017;63(4):278–285.
   PubMed Web of Science ®Google Scholar
• Bhaskar K, Anbu J, Ravichandiran V, et al. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis. 2009;8(1):6.
   PubMedGoogle Scholar
• Jangle R, Thorat B. Reversed-phase high-performance liquid chromatography method for analysis of curcuminoids and curcuminoid-loaded liposome formulation. Indian J Pharm Sci. 2013;75(1):60–66.
   PubMed Web of Science ®Google Scholar
• Avasatthi V, Pawar H, Dora CP, et al. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Pharm Dev Technol. 2016;21(5):554–562.
   PubMed Web of Science ®Google Scholar
• Gaba B, Fazil M, Khan S, et al. Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride. Bull Faculty Pharmacy, Cairo Univ. 2015;53(2):147–159.
   Google Scholar
• Kaur P, Garg T, Rath G, et al. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design. Drug Deliv. 2016;23(6):1912–1925.
   PubMed Web of Science ®Google Scholar
• Kasongo W, Pardeike J, Müller RH, et al. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. J Pharm Sci. 2011;100(12):5185–5196.
   PubMed Web of Science ®Google Scholar
• Vanaja K, Shobha Rani R. Design of experiments: concept and applications of Plackett Burman design. Clin Res Regul Aff. 2007;24(1):1–23.
   Google Scholar
• Jain A, Hurkat P, Jain SK. Development of liposomes using formulation by design: basics to recent advances. Chem Phys Lipids. 2019;224:104764.
   PubMed Web of Science ®Google Scholar
• Verma A, Sharma G, Jain A, et al. Systematic optimization of cationic surface engineered mucoadhesive vesicles employing Design of Experiment (DoE): a preclinical investigation. Int J Biol Macromol. 2019;133:1142–1155.
   PubMed Web of Science ®Google Scholar
• Ferreira SC, Bruns R, Ferreira H, et al. Box-Behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta. 2007;597(2):179–186.
   PubMed Web of Science ®Google Scholar
• Gomes MJ, Martins S, Ferreira D, et al. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies. Int J Nanomedicine. 2014;9:1231–1242.
   PubMed Web of Science ®Google Scholar
• Gee GW, Or D. 2.4 Particle-size analysis. Methods Soil Anal Part. 2002;4(598):255–293.
   Google Scholar
• Prajapati SK, Jain A, Shrivastava C, et al. Hyaluronic acid conjugated multi-walled carbon nanotubes for colon cancer targeting. Int J Biol Macromol. 2019;123:691–703.
   PubMed Web of Science ®Google Scholar
• Luo Q, Zhao J, Zhang X, et al. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm. 2011;403(1–2):185–191.
   PubMed Web of Science ®Google Scholar
• Chen H, Gao J, Wang F, et al. Preparation, characterization and pharmacokinetics of liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs. Drug Deliv. 2007;14(4):201–208.
   PubMed Web of Science ®Google Scholar
• Peltonen L, Aitta J, Hyvönen S, et al. Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly (I) lactide nanoparticles. AAPS PharmSciTech. 2004;5(1):115–120.
   PubMed Web of Science ®Google Scholar
• Ranpise NS, Korabu SS, Ghodake VN. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Colloids Surf B Biointerfaces. 2014;116:81–87.
   PubMed Web of Science ®Google Scholar
• Shinde G, Rajesh K, Prajapati N. Formulation, development and characterization of nanostructured lipid carrier (NLC) loaded gel for psoriasis. Scholar Research Library. 2013;5(4):13–25.
   Google Scholar
• Jalili N, Laxminarayana K. A review of atomic force microscopy imaging systems: application to molecular metrology and biological sciences. Mechatronics. 2004;14(8):907–945.
   Web of Science ®Google Scholar
• Patel D, Dasgupta S, Dey S, et al. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. Sci Pharm. 2012;80(3):749–764.
   PubMedGoogle Scholar
• Phatak AA, Chaudhari PD. Development and evaluation of Nanostructured Lipid Carrier (NLC) based topical delivery of an anti-inflammatory drug. J Pharm Res. 2013;7(8):677–685.
   Google Scholar
• Lin Y-K, Huang Z-R, Zhuo R-Z, et al. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomed. 2010;5:117–128.
   PubMed Web of Science ®Google Scholar
• Khurana S, Bedi P, Jain N. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam. Chem Phys Lipids. 2013;175-176:65–72.
   PubMed Web of Science ®Google Scholar
• Nighojkar PA, Devi SU, Pund KV, et al. Formulation development of BMP-NLC enriched gel. Int J Pharm Sci Res. 2012;3(9):3522.
   Google Scholar
• Antonijević MD, Novac O, O'Hagan BM. Can emollients of similar composition be assumed to be therapeutically equivalent: a comparison of skin occlusivity and emulsion microstructure. Clin Cosmet Invest Dermatol. 2018;11:461–465.
   PubMed Web of Science ®Google Scholar
• Kumar S, Malick AW, Meltzer NM, et al. Studies of in vitro skin permeation and retention of a leukotriene antagonist from topical vehicles with a hairless guinea pig model. J Pharm Sci. 1992;81(7):631–634.
   PubMed Web of Science ®Google Scholar
• Jones PJ, Jew S, AbuMweis S. The effect of dietary oleic, linoleic, and linolenic acids on fat oxidation and energy expenditure in healthy men. Metabolism. 2008;57(9):1198–1203.
   PubMed Web of Science ®Google Scholar
• Cirri M, Maestrini L, Maestrelli F, et al. Design, characterization and in vivo evaluation of Nanostructured Lipid Carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Drug Deliv. 2018;25(1):1910–1921.
   PubMed Web of Science ®Google Scholar
• Pokharkar VB, Shekhawat PB, Dhapte VV, et al. Development and optimization of eugenol loaded nanostructured lipid carriers for periodontal delivery. Int J Pharm Pharm Sci. 2011;3(4):138–143.
   Google Scholar
• Agrawal Y, Petkar KC, Sawant KK. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 2010;401(1-2):93–102.
   PubMed Web of Science ®Google Scholar
• Triplett MD, Rathman JF. Optimization of β-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique. J Nanopart Res. 2009;11(3):601–614.
   Web of Science ®Google Scholar
• Thakkar HP, Desai JL, Parmar MP. Application of Box-Behnken design for optimization of formulation parameters for nanostructured lipid carriers of candesartan cilexetil. Asian J Pharm. 2014;8(2):81.
   Google Scholar
• Gönüllü Ü, Üner M, Yener G, et al. Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery. Acta Pharmaceutica. 2015;65(1):1–13.
   PubMed Web of Science ®Google Scholar
• Cheng-Ying S, Ling D, Bao-De S, et al. Nanostructured lipid carrier based topical gel of Ganoderma Triterpenoids for frostbite treatment. Chin J Nat Med. 2015;13(6):454–460.
   PubMed Web of Science ®Google Scholar
• Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems – a review (Part 2). Trop J Pharm Res. 2013;12(2):265–273.
   Google Scholar
• Tamjidi F, Shahedi M, Varshosaz J, et al. Design and characterization of astaxanthin-loaded nanostructured lipid carriers. Innovative Food Sci Emerg Technol. 2014;26:366–374.
   Web of Science ®Google Scholar
• Attama AA. Momoh MA, Builders PF. Lipid nanoparticulate drug delivery systems: a revolution in dosage form design and development. In: Recent advances in novel drug carrier systems. London: IntechOpen; 2012.
   Google Scholar
• Khalil RM, El-Bary AA, Kassem MA, et al. Solid lipid nanoparticles for topical delivery of meloxicam: development and in vitro characterization. Eur Sci J. 2013;9(21):125–136.
   Google Scholar
• Bhalekar MR, Pokharkar V, Madgulkar A, et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech. 2009;10(1):289–296.
   PubMed Web of Science ®Google Scholar
• Zhou H, Qiu L, Yan X, et al. Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers. Yao xue xue bao=. Yao Xue Xue Bao. 2010;45(9):1177–1182.
   PubMedGoogle Scholar
• Deepika D, Dewangan HK, Maurya L, et al. Intranasal drug delivery of frovatriptan succinate-loaded polymeric nanoparticles for brain targeting. J Pharm Sci. 2019;108(2):851–859.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Müller RH, Junyaprasert VB. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) – effects of formulation parameters on physicochemical stability . Int J Pharm. 2007;340(1-2):198–206.
   PubMed Web of Science ®Google Scholar
• Joshi M, Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm. 2008;346(1-2):124–132.
   PubMed Web of Science ®Google Scholar
• Seo D-S, Oh-Ide T, Matsuda H, et al. Surface morphology of the rubbed polyimide and polystyrene films and their liquid crystal aligning capability. Mol Crystals Liquid Crystals Sci Technol Sect A: Mol Crystals Liquid Crystals. 1993;231(1):95–106.
   Web of Science ®Google Scholar
• Jain A, Jain SK. Multipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer. Drug Dev Ind Pharm. 2016;42(1):136–149.
   PubMed Web of Science ®Google Scholar
• Jain A, Jain SK. In vitro release kinetics model fitting of liposomes: an insight. Chem Phys Lipids. 2016;201:28–40.
   Web of Science ®Google Scholar
• Xia Q, Saupe A, Müller R, et al. Nanostructured lipid carriers as novel carrier for sunscreen formulations. Int J Cosmet Sci. 2007;29(6):473–482.
   PubMedGoogle Scholar
• Shah PP, Desai PR, Patel AR, et al. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials. 2012;33(5):1607–1617.
   PubMed Web of Science ®Google Scholar
• Ricci M, Puglia C, Bonina F, et al. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J Pharm Sci. 2005;94(5):1149–1159.
   PubMed Web of Science ®Google Scholar
• Asadi H, Rostamizadeh K, Salari D, et al. Preparation and characterization of tri-block poly(lactide)-poly(ethylene glycol)-poly(lactide) nanogels for controlled release of naltrexone. Int J Pharm. 2011;416(1):356–364.
   PubMedGoogle Scholar
• Shrotriya S, Ranpise N, Satpute P, et al. Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis. Artif Cells Nanomed Biotechnol. 2018;46(7):1471–1482.
   PubMed Web of Science ®Google Scholar
• Wavikar P, Vavia P. Nanolipidgel for enhanced skin deposition and improved antifungal activity. AAPS PharmSciTech. 2013;14(1):222–233.
   PubMed Web of Science ®Google Scholar
• Campos PM, Bentley MV, Torchilin VP. Nanopreparations for skin cancer therapy. In Nanobiomaterials in cancer therapy. William Andrew Publishing; 2016. p. 1-28.
   Google Scholar
• Gianeti MD, Wagemaker AL, Seixas VC, et al. The use of nanotechnology in cosmetic formulations: the influence of vehicle in the vitamin A skin penetration. Curr Nanosci. 2012;8(4):526–534.
   Web of Science ®Google Scholar